Canine CD20 Full Length Protein (VLP)
Canine CD20 Full Length Protein (VLP) (CD0-C52P3) is expressed from human 293 cells (HEK293) . It contains AA Met 1 - Pro 297 (Accession # Q3C2E2-1) .
Product Specifications
Background
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. This protein can be used for screening and validation of dog CD20 antibody.
Specifications
This protein .
Accession Number
Q3C2E2-1
Expression Region
Met 1 - Pro 297
Host
HEK293
Target
CD20
Conjugation
Unconjugated
Tag
-
Source
Canine
Stability
● The product MUST be stored at -70°C or lower upon receipt; ● -70°C for 12 months under sterile conditions.
Endotoxin
1.0 EU per μg
Bioactivity
Immobilized Canine CD20 Full Length Protein (VLP) (Cat. No. CD0-C52P3) at 2 μg/mL (100 μL/well) can bind Anti-CD20 antibody with a linear range of 0.01-0.625 μg/mL (QC tested).
Format
Liquid
Buffer
PBS, Arginine, pH7.4
Additives
Trehalose
Shipping Conditions
Dry ice
Storage Conditions
-70°C
Package Size
20ug*1
Product Datasheet
Https://www.acrobiosystems.com/static/main/products/pdf/ds/CD0-C52P3.pdf
Species
Canine
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL311833V 500 µL Each
Cytokeratin 2 (KRT2) Human shRNA Lentiviral Particle (Locus ID 3849)
Ask
View Details 